Provided by Tiger Trade Technology Pte. Ltd.

NANOBIOTIX SPON ADS EACH REP 1 ORD SHS

41.23
-3.9300-8.70%
Post-market: 41.230.00000.00%17:32 EDT
Volume:164.86K
Turnover:6.96M
Market Cap:2.09B
PE:-70.23
High:45.03
Open:44.55
Low:40.49
Close:45.16
52wk High:57.14
52wk Low:8.03
Shares:50.71M
Float Shares:35.58M
Volume Ratio:0.77
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5871
EPS(LYR):-0.5871
ROE:--
ROA:-10.06%
PB:-21.35
PE(LYR):-70.23

Loading ...

Earnings Flash (NBTX) Nanobiotix Posts 2025 Revenue 32.6M Euros

MT Newswires Live
·
Apr 01

Earnings Flash (NBTX) Nanobiotix Posts 2025 Per-Share Loss 0.50 Euro

MT Newswires Live
·
Apr 01

Nanobiotix FY EPS $(0.58) Down From $1.56 YoY, Sales $37.943M Miss $165.540M Estimate

Benzinga Earnings
·
Apr 01

Press Release: NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results

Dow Jones
·
Apr 01

Nanobiotix price target raised to EUR 32 from EUR 23 at H.C. Wainwright

TIPRANKS
·
Mar 31

Nanobiotix presents first data from CONVERGE study

TIPRANKS
·
Mar 30

NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer

GlobeNewswire
·
Mar 30

Press Release: NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026

Dow Jones
·
Mar 27

Nanobiotix Denies Takeover Speculations

MT Newswires Live
·
Mar 26

Nanobiotix says ‘no such intention’ for company to acquire control

TIPRANKS
·
Mar 25

Press Release: NANOBIOTIX Statement Regarding Recent Media Speculation

Dow Jones
·
Mar 25

NANOBIOTIX SPON ADS EACH REP 1 ORD SHS (NBTX.US) Surges on Acquisition Speculation Involving Johnson & Johnson (JNJ.US)

Stock News
·
Mar 25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Nanobiotix (NBTX), ImageneBio (IMA) and Dianthus Therapeutics (DNTH)

TIPRANKS
·
Mar 12

NANOBIOTIX to Participate in Investor Conferences in March

GlobeNewswire
·
Feb 26

Nanobiotix Sa : TD Cowen Initiates Coverage With Buy Rating

THOMSON REUTERS
·
Feb 06

Nanobiotix: Differentiated Radiotherapy Enhancer, J&J Partnership, and Multi-Indication Pipeline Undervalue Long-Term Upside, Supporting Buy Rating

TIPRANKS
·
Feb 06

Nanobiotix to Join CAC Indexes

MT Newswires Live
·
Dec 15, 2025

NANOBIOTIX to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris

GlobeNewswire
·
Dec 15, 2025